Beta-human papillomaviruses (b-HPV) infect cutaneous epithelia, and accumulating evidence suggests that the virus may act as a co-factor with UV-induced DNA damage in the development and progression of non-melanoma skin cancer, although the molecular mechanisms involved are poorly understood. The E6 protein of cutaneous b-HPV types encodes functions consistent with a role in tumorigenesis, and E6 expression can result in papilloma formation in transgenic animals. The E6 proteins of high-risk a-HPV types, which are associated with the development of anogenital cancers, have a conserved 4 aa motif at their extreme C terminus that binds to specific PDZ domain-containing proteins to promote cell invasion. Likewise, the high-risk b-HPVs HPV5 and HPV8 E6 proteins also share a conserved C-terminal motif, but this is markedly different from that of a-HPV types, implying functional differences. Using binding and functional studies, we have shown that b-HPV E6 proteins target b 1 -integrin using this C-terminal motif. E6 expression reduced membrane localization of b 1 -integrin, but increased overall levels of b 1 -integrin protein and its downstream effector focal adhesion kinase in human keratinocytes. Altered b 1 -integrin localization due to E6 expression was associated with actin cytoskeleton rearrangement and increased cell migration that was abolished by point mutations in the C-terminal motif of E6. We concluded that modulation of b 1 -integrin signalling by E6 proteins may contribute towards the pathogenicity of these b-HPV types.
INTRODUCTION
UV-induced damage to keratinocytes is the main aetiological factor in the development of non-melanoma skin cancer (NMSC). Keratinocytes are the host cells of human papillomavirus (HPV) infection and the HPV life cycle is tightly coupled to the keratinocyte differentiation programme. HPVs encode genes that promote keratinocyte survival and proliferation after UV exposure and uncouple cell-cycle exit from differentiation (Hudson et al., 1990; Jones et al., 1997) . Infection with high-risk b-HPVs is associated with the development of NMSC, the most commonly diagnosed cancer in Caucasians (Diepgen & Mahler, 2002; Kiviat, 1999) . HPVs of the genus Betapapillomavirus (formerly known as Epidermodysplasia verruciformis or EV types) exhibit cutaneous tropism where EV individuals are prone to infection with these viral types. EV individuals have a propensity to develop NMSC at sunexposed body sites as early as the age of 20 years (Gül et al., 2007) , where infection with the b1-HPV types 5 and 8 are associated with the highest risk of malignancy (Orth, 1986; Pfister, 2003; Pfister & Ter Schegget, 1997) . In more recent epidemiological studies, a high percentage of squamous cell carcinoma (SCC) isolated from immunocompromised organ transplant recipients was found to contain b-HPV DNA (Harwood et al., , 2004 Proby et al., 2011; Weissenborn et al., 2012) and the immunocompromised population has a 200-fold increased risk of SCC formation compared with the immunocompetent population (Hartevelt et al., 1990; Stockfleth et al., 2001) . Whilst the association between infection with the mucosal a-HPVs and cervical cancer is well characterized and contributory mechanisms established, in contrast, that of b-HPVs and NMSC development is not as clearly defined, but it is likely that the virus acts in a co-factorial role in concert with the deleterious effects of UV exposure.
The E6 protein of high-risk a-HPVs is well characterized in terms of the degradation of the p53 tumour suppressor protein (Huibregtse et al., 1991; Scheffner et al., 1990; Werness et al., 1990) , which contributes to the tumorigenic potential of high-risk a-HPV E6 proteins. E6 proteins encoded by b-HPVs do not in general share this function; however, a recent report suggested that the HPV49 E6 protein is able to target p53 for degradation to some degree (Cornet et al., 2012) , but whether this is dependent on the p53 isoform (Storey et al., 1998) , as noted previously for specific mutants of HPV5 E6 (Simmonds & Storey, 2008) , remains to be determined. Nevertheless, transgenic mice expressing the HPV8 E6 protein mimic expression of the complete early region of the HPV8 genome, in that E6 expression leads to papilloma formation, which can progress spontaneously to SCC (Marcuzzi et al., 2009) . Therefore, b-HPV E6 proteins have tumorigenic potential independent of the degradation of p53. UV irradiation of transgenic HPV8 E6 mice results in a synergistic increase in SCC formation (Marcuzzi et al., 2009) . The E6 proteins of b-HPVs may exacerbate the mutagenic effects of UV irradiation by delaying the repair of UV-induced thymine dimers (Giampieri & Storey, 2004 ) through targeting of the DNA damage-response proteins ATR and XRCC1 (Iftner et al., 2002; Wallace et al., 2012) and elimination of the apoptotic response to irreparable DNA damage , which may increase genomic instability to promote tumorigenesis (Jackson et al., 2002) . Expression of b-HPV E6 types HPV8 and -38 also prevents keratinocyte differentiation through targeting of MAML-1 in the Notch pathway (Brimer et al., 2012; Tan et al., 2012) and perturbs cell-survival signalling through disruption of the association of the transcriptional coactivator p300 with AKT, a key factor in promoting cell survival (Howie et al., 2011) .
Interestingly, the b-HPV E6 proteins also differ from those of high-risk a-HPV as b-HPV E6 proteins lack a conserved ETQV/L motif located at the extreme C terminus of the protein, as described for HPV16 and -18. The ETQV/L motif mimics a known PDZ domain-binding consensus sequence (X-T/S-X-V), and subsequently a-HPV E6 proteins use this motif to target specific PDZ domaincontaining proteins for degradation. Such proteins include membrane-associated guanylate kinase inverted (MAGI) family members , MUPP1 (multi-PDZ domain protein 1; Lee et al., 2000) , Scribble (Nakagawa & Huibregtse, 2000) and Dlg (Gardiol et al., 1999) . Normally, these proteins function to maintain cell polarity and adhesion; however, using the ETQL/V motif, E6 disrupts cell-junction formation and actin cytoskeleton organization that correlates with the transformation of keratinocytes (Watson et al., 2003) . Transgenic mice expressing a-HPV E6 C-terminal truncation mutants, which are able to inactivate p53 but unable to target PDZ proteins, do not exhibit epithelial hyperplasia (Nguyen et al., 2003) , and loss of the ETQV/L motif results in partial reversal of the epithelial-mesenchymal transition associated with HPV infection (Watson et al., 2003) . Addition of the ETQV/L motif to low-risk a-HPV E6 proteins enables them to target PDZ domain proteins; however, addition of the motif to b-HPV E6 proteins does not (Pim et al., 2002) , highlighting the intrinsic differences between E6 proteins from different HPV genera.
Intriguingly, some b1-HPV E6 proteins associated with the highest risk for malignancy (Harwood et al., , 2004 Orth, 1986; Pfister, 2003; Pfister & Ter Schegget, 1997; Proby et al., 2011; Weissenborn et al., 2012) , including those of HPV5 and -8, have a conserved C-terminal motif of YHDW, but as yet there are no data to indicate its functional significance. Here, we identified b 1 -integrin as an interacting protein of the YHDW motif and showed that E6 expression disrupts normal integrin signalling through focal adhesion kinase (FAK), which is associated with increased cell migration. These findings provide new insights into the mechanisms by which high-risk cutaneous HPV E6 proteins may contribute to malignancy.
RESULTS

Identification of proteins interacting with the E6 YHDW motif
The E6 proteins encoded by the high-risk b-HPVs HPV5 and -8 share a YHDW motif at their C terminus, with the YXDW sequence being conserved at the C terminus of other b1-type HPV E6 proteins (Table 1 ). The His is often replaced by an Asn residue, suggesting conservation of a basic amino acid, but whilst host-cell-interacting proteins of most of these b1-HPVs are unknown, the motif is not conserved in other HPV E6 proteins associated with SCC formation, such as HPV20 (b1) and HPV38 (b2). As the ETQV/L motif of high-risk a-HPV E6 proteins is associated with the hyperproliferative and transformed phenotype observed upon expression of these E6 proteins, we hypothesized that a different spectrum of proteins may interact with this motif, which may play an important role in E6 function.
To probe for proteins that were able to interact with the YHDW sequence, a haemagglutinin (HA)-tagged peptide with flexible Gly-Ser-Ser repeat region with the YHDW motif at the C terminus, or a control peptide lacking the YHDW residues, was incubated with a whole-cell lysate prepared from N-TERT keratinocytes. The protein-peptide complexes were immunoprecipitated using anti-HA-conjugated agarose beads, eluted and then separated by SDS-PAGE and visualized by silver staining. Areas of the gel showing differences in banding pattern between the control peptide and YHDW peptide were excised (Fig. 1a) , the isolated proteins were subjected to trypsin digestion and the resultant peptides were analysed and identified by liquid chromatography-coupled mass spectrometry (LC-MS). Unique interacting proteins of the YHDW peptide were classified by identification of two peptides or more, with at least one peptide with a significance of P¡0.05 to indicate significant homology. Although four proteins were identified as unique YHDW-interacting proteins using these criteria (Table 2) , we focused subsequently on the transmembrane receptor b 1 -integrin subunit. Integrin-b 1 is potentially a very interesting E6-interacting protein as it regulates cell polarity, adhesion and migration, as part of a heterodimer with an a-integrin subunit.
Expression of HPV5 or -8 E6 increases the total levels of b 1 -integrin and downstream effectors
To assess the functional significance of the effects of HPV E6 protein expression on b 1 -integrin function, and in particular the contribution of the YHDW motif, N-TERT keratinocytes were transduced with recombinant pLXSNbased retroviruses to express the HPV5, -8 or -20 E6 proteins, as described previously (Akgül et al., 2010; Tomlins & Storey, 2010) . For comparative purposes, HPV20 was selected as a b1-HPV type commonly detected in NMSC of renal transplant recipients (de Villiers et al., 1997) and implicated in SCC formation by murine studies (Michel et al., 2006) but lacking the YHDW consensus motif of HPV5 and -8 E6 proteins. To probe further, and in greater detail, the contribution of the YHDW motif to the perturbation of b 1 -integrin function, the mutation D156A or W157A was generated at the C terminus of the HPV5 E6 protein (Fig. 2a) and expression of these constructs confirmed by reverse transcriptase (RT)-PCR (Fig. 2b) . Whilst other mutations generated across the HPV5 E6 protein do not affect its stability (Simmonds & Storey, 2008) , we cannot rule out at this time whether or not these mutations at the C terminus alter E6 structure or stability. Empty lanes were left between each sample on the gel to limit sample cross-contamination (indicated by the background staining observed). Corresponding regions of the gel, visibly identified as differing, between the control and YHDW peptide pull-downs were excised, denoted 'A', 'B' and 'C'. Proteins extracted from these regions were extracted and trypsin digested, and the resultant peptides analysed by liquid chromatography-coupled mass spectrometry. HMM, high molecular mass.
As a number of E6-interacting proteins that have been identified so far are targeted for proteolysis (Howie et al., 2011; Jha et al., 2010) , we first examined, by Western blotting, whether the total levels of b 1 -integrin were altered in N-TERT cells expressing the different E6 constructs. As integrins do not have intrinsic enzymic activity, they signal through effector proteins in order to modulate cell activity and control a number of downstream intracellular signalling pathways. Such effectors include FAK, paxillin and vinculin through which integrins mediate focal adhesion formation that mediates cell attachment to the extracellular matrix and actin cytoskeleton arrangement. Interestingly, high-risk a-HPV E6 proteins disrupt focal adhesion formation (Ben Khalifa et al., 2011) , and targeting of paxillin is required for the transforming ability of bovine papillomavirus type 1 E6 (Wade et al., 2008) . We supposed then that disruption of this pathway might be an important activity for b1-HPV types; hence, we also determined the levels of FAK, vinculin and paxillin in E6-expressing cells (Fig. 2c ).
Upon expression of HPV5 and -8 E6 proteins in N-TERT cells, an increase in b 1 -integrin levels was observed when compared with control cells harbouring empty vector. In contrast, cells expressing the HPV20 E6 protein exhibited lower b 1 -integrin levels compared with HPV5 or -8 E6-expressing cells. N-TERT cells expressing the D156A mutant HPV5 E6 protein also had increased b 1 -integrin levels that were comparable to cells expressing the WT HPV5 E6 protein. By contrast, when compared with HPV5 E6-expressing cells, b 1 -integrin levels were not elevated in cells expressing the W157A mutant. We also found that there was a close correlation between the changes in the total levels of b 1 -integrin with the levels of FAK, paxillin and vinculin, suggesting that increased levels of b 1 -integrin, induced by high-risk b-HPV E6 expression, linked to the integrity of the YHDW motif, was associated with increased levels of these downstream signalling effectors.
Altered localization of b 1 -integrin and levels of FAK are dependent on the E6 YHDW motif
Integrin-b 1 is localized largely to cell membranes in order to mediate adhesion to the extracellular matrix. As increased total b 1 -integrin and downstream effector levels had been observed previously in cells expressing HPV5 or -8 E6, we next investigated the membrane localization of b 1 -integrin in the E6-expressing N-TERT cells. Cells were permeabilized using Triton X-100 and b 1 -integrin stained using the P5D2 antibody, which recognizes the b 1 -integrin extracellular domain. FAK localization was examined simultaneously, as we found changes in total levels correlated with those of b 1 -integrin.
In cells harbouring empty vector, a characteristic compact, honeycomb-like membrane localization of b 1 -integrin was readily apparent (Fig. 3) . By contrast, and unexpectedly, membrane staining of b 1 -integrin in HPV5 or -8 E6-expressing N-TERT cells was reduced. The level of b 1 -integrin staining in HPV20 E6-expressing cells appeared higher than that of those expressing HPV5 or -8 E6, but was not as well defined at the membrane as that observed in empty vector-expressing cells. Cells expressing the HPV5 E6 D156A or W157A mutant showed increased b 1 -integrin staining at the cell membrane compared with cells expressing the WT protein; however, cells expressing the HPV5 E6 W157A mutant showed elevated concentrations of b 1 -integrin staining in the regions of cell contact (Fig. 3) .
Concomitant with the b 1 -integrin staining, FAK immunofluorescence showed a diffuse cytoplasmic staining pattern in all cell lines. Again, in contrast to the correlation between the total FAK and b 1 -integrin levels observed in Fig. 2(c) , surprisingly, the level of FAK staining exhibited an inverse relationship to that observed for b 1 -integrin in cell lines expressing each of the E6 constructs (Fig. 3) . The lowest FAK staining was observed in empty vector-and HPV20 E6-expressing cells, whilst the highest levels were exhibited in cells expressing the HPV5 and -8 E6 proteins. In contrast to Western blotting of FAK levels in the cells expressing the different E6 constructs (Fig. 2c) , mutation of residue W157 did not reduce levels of FAK by immunofluorescence in comparison with cells expressing the WT protein.
As a transmembrane receptor, b 1 -integrin is constantly internalized and subjected to intracellular vesicle trafficking. As the P5D2 b 1 -integrin antibody used in Fig. 3 recognizes an epitope in the extracellular domain of b 1 -integrin and Triton X-100 treatment is thought not to reveal the intracellular membrane protein fraction (Goldenthal et al., 1985) , we hypothesized that the differences observed in b 1 -integrin levels between Figs 2 and 3 might be the result of increased b 1 -integrin internalization into intracellular vesicles (Vassilieva et al., 2008) . Subsequently immunofluorescent staining of b 1 -integrin in N-TERT cells expressing the HPV E6 constructs was repeated under different permeabilization conditions with saponin, which better preserves membrane structure and detection of intracellular membrane proteins (Fig. 4) 
High-risk E6 expression promotes actin rearrangement and increased cell migration
Integrins, through mediation of cellular adhesion to the extracellular matrix, play a large role in cell migration, sensing extracellular growth signals and initiating the formation of new adhesion points to direct cell movement. This results in rearrangement of the actin cytoskeleton. We hypothesized that the altered b 1 -integrin localization upon high-risk E6 expression observed in Figs 3 and 4 , and the increased total levels of b 1 -integrin and associated proteins in Fig. 2 , might be associated with disruption of the actin cytoskeleton and/or increased cellular migration. Probing of the filamentous actin (F-actin) cytoskeleton arrangement using fluorescently labelled phalloidin, 6 h after scratch wounding the cell monolayer in order to promote cell migration, revealed that empty vector-expressing cells showed a compact actin staining adjacent to the wound with few cellular protrusions into the wound (Fig. 5) . In contrast, actin filaments in migratory HPV5 and -8 E6-expressing cells appeared more disorganized and less compact, with a greater number of protrusions around the cells. The actin fibres in cells expressing HPV20 E6 exhibited a phenotype most similar to that of empty vector-expressing cells. Expression of the HPV5 E6 D156A mutant in cells, like the WT protein, resulted in actin fibre disorganization and an increased number of cellular protrusions at the wound edge; however, these effects were diminished in cells expressing the W157A mutant. These data suggested that expression of the HPV5 or -8 E6 proteins leads to disruption of the cytoskeleton and that residue W157 of the HPV5 E6 protein contributes to this phenotype.
The differences observed in the actin cytoskeleton among the HPV E6-expressing cell lines, particularly in the migrating cells at the wound leading edge, suggested that expression of the E6 proteins may alter cell migration. Therefore, a scratch-wound assay was performed and the percentage wound closure was monitored and calculated using the Incucyte system (EssenBio; Fig. 6a ). Fig. 6(b) shows representative images of wound closure 6 h after wounding. Fig. 6(a) shows that cells expressing the HPV5 E6 protein migrated fastest, achieving almost 100 % closure by 10 h. In contrast to the HPV5 E6 cells, control pLXSN cells achieved only~70 % wound closure by the 10 h time point (P50.12). Interestingly, the migration of cells expressing the HPV8 E6 protein was initially slower than that of cells expressing the empty vector; however, 6-8 h after scratching, the migration rate of HPV8 E6-expressing cells increased to result in the higher percentage wound closure observed at 10 h. Cells expressing HPV20 E6 consistently exhibited slower migration than the HPV5 E6 cells (P50.03). Cells expressing the HPV5 E6 D156A mutant initially migrated more rapidly than those expressing the WT protein and achieved~100 % closure by 10 h, whilst expression of the W157A mutant reduced the rate of migration when compared with expression of the WT protein (P50.15). Together, these findings suggested that the C-terminal YHDW motif makes an important contribution to the increased migration observed upon HPV5 E6 protein expression, and that the W157 terminal residue plays an important functional role in this activity.
DISCUSSION
A function for the C-terminal ETQV/L motif of high-risk a-HPV E6 proteins in disrupting cell adhesion and polarity has been identified and well studied. However, binding partners and possible functions of the conserved Cterminal YHDW motif of high-risk b1-HPV E6 proteins have not been explored previously. We identified cellular proteins that interacted with this motif through peptide pull-down, and subsequently focused on b 1 -integrin. Integrin-b 1 is an exciting E6-interacting protein as it plays a critical role in promoting cell survival, proliferation and migration, differentiation and angiogenesis (Brakebusch & Fässler, 2005; Chan et al., 2007; Mettouchi & Meneguzzi, 2006) . Furthermore, in earlier work, integrin-b 1 was found to be enriched in keratinocyte stem cells (Jones & Watt, 1993) , believed to be the reservoir of HPV in latent infections (Moody & Laimins, 2010) . Integrin-b 1 has been identified previously as an interacting protein of both lowand high-risk a-HPV E5 proteins (Rozenblatt-Rosen et al.,
2012), and recently of the HPV8 E6 protein (Howie et al., 2011) . As b-HPVs do not encode the E5 protein, the findings here suggest that the b-HPV E6 proteins evolved Cutaneous HPV E6 proteins disrupt b 1 -integrin function to disrupt b 1 -integrin function through the YHDW motif, implicating modulation of b 1 -integrin function, and disruption of cell adhesion complexes, as an important activity of both b-and a-HPVs.
Using immunofluorescent staining of b 1 -integrin, we showed that expression of b-HPV E6 proteins that share the YHDW motif resulted in reduced membrane localization of b 1 -integrin coupled with increased b 1 -integrin cytoplasmic staining (Figs 3 and 4) . This is an important finding as b 1 -integrin internalization and trafficking play a large role in cell migration: removing integrins from focal adhesions at one point and trafficking them to a different location on the plasma membrane to lay down new adhesion points. Endocytosis of integrin heterodimers, containing b 1 -integrin, is required to allow focal adhesion disassembly (Ezratty et al., 2009; Vassilieva et al., 2008) , and blocking integrin trafficking blocks cell migration (Ng et al., 1999; Shen et al., 2012) . Furthermore, a functionblocking antibody to b 1 -integrin blocks b 1 -integrin internalization, suggesting that internalization occurs in response to activation (Du et al., 2011) . Our findings suggest that specific b-HPV E6 proteins may alter the activity of this critical signalling pathway and, interestingly, HPV16 E6 has recently been shown to increase activated receptor protein tyrosine kinase internalization and signalling to increase primary keratinocyte migration (Spangle & Munger, 2013) .
Integrins lack intrinsic enzymic activity, but receptor activation results in FAK autophosphorylation and here we found, concomitant with reduced b 1 -integrin membrane localization, increased FAK levels and increased levels of the FAK target proteins vinculin and paxillin (Fig.  2) . Increased FAK levels have been associated with infection with high-risk mucosal HPVs (McCormack et al., 1997); however, this was not attributed to expression of a particular HPV protein. The association between a-HPV infection and increased FAK levels correlated with elimination of anoikis (McCormack et al., 1997) and raised levels of FAK are linked to increased cell migration, which, in turn, is linked to metastatic potential (Slack et al., 2001) . Interestingly, cells isolated from SCC expressing high levels of a 6 b 1 -integrin with increased FAK signalling are proposed to meet the criteria for definition as cancer stem cells (Schober & Fuchs, 2011) .
Through FAK, vinculin and paxillin, integrins regulate the actin cytoskeleton. We therefore undertook studies to investigate F-actin cytoskeleton arrangement and cell migration upon b-HPV E6 expression (Figs 5 and 6 ). We showed that cells expressing the high-risk cutaneous HPV5 E6 protein exhibited increased cell migration, suggesting that disturbance of b 1 -integrin function by E6 proteins of high-risk b-HPVs, through FAK, leads to increased cell migration. Whether extracellular matrix proteins, such as collagens and fibronectin (Humphries et al., 2006) , that are ligands for integrins (Humphries et al., 2006) impact on the migration of the keratinocytes expressing E6 proteins awaits further analysis. Disruption of the actin cytoskeleton by cutaneous HPV E7 proteins has previously been observed (Akgül et al., 2009) , possibly through downregulation of some actin-binding proteins, but our results now suggest that the high-risk cutaneous HPV E6 proteins may also target the actin skeleton directly, using a different mechanism to that observed previously.
Although the high-risk a-HPV E6 proteins are able to bind PDZ domain proteins, they exhibit variation in the final Cterminal motif. HPV18 E6 has a consensus PDZ domainbinding sequence (ETQV), whilst HPV16 E6 terminates with the amino acids ETQL. Consequently, these E6 proteins bind and target PDZ domain proteins that have differing functions with different affinities (Gardiol et al., 1999; Kiyono et al., 1997; Pim et al., 2000; Thomas et al., 2005) . Generally, the ETQV/L motif inserts into a peptidebinding loop within the PDZ domain, formed by the strand bB and the helix ab (Zhang et al., 2007) . It is therefore interesting that there is no variation between the HPV5 and -8 E6 proteins, suggesting a strict conservation of function. Studies have shown that phosphorylation of the ETQV/L motif of the high-risk HPV types by protein kinase A inhibits the ability of the protein to bind PDZ motifs (Kühne et al., 2000; Zhang et al., 2007) , and mutation of this region impacts on the phenotype of E6-expressing cells (Watson et al., 2003) . However, interrogation of the PHOSIDA and NetPhos2.0 prediction tools suggests that the YHDW motif is not likely to be a phosphorylation site, implying that the regulation of function of the different C-terminal motifs is not conserved. In addition, the YHDW motif is not a recognized motif found in other cellular proteins. Furthermore, BLAST database analysis did not reveal any homology to cellular proteins, suggesting that this motif is not conserved among human cellular proteins. In the mutational analyses, greater functional importance was attributed to residue W157, a bulky hydrophobic amino acid, than to the negatively charged residue D156 in the targeting of b 1 -integrin function. This may indicate that a steric interaction is required in highrisk cutaneous HPV targeting, analogous to that known to be required for high-risk a-HPV in PDZ targeting.
For normal development of the epidermis, keratinocyte functions of differentiation, proliferation, adhesion and migration are strictly coupled. Integrin-b 1 plays an important role in regulating many of these pathways and is essential for epidermal maintenance and integrity (Brakebusch et al., 2000; Simpson et al., 2011) . Hence, b 1 -integrin expression is normally tightly regulated and deregulation of b 1 -integrin may contribute to malignancy. Indeed, ectopic expression in the suprabasal layers of transgenic mice results in hyperproliferation, perturbed keratinocyte differentiation and a psoriasis-like phenotype (Carroll et al., 1995; Hertle et al., 1992) .
During wounding, keratinocytes must, temporarily, adopt a more 'active' phenotype, becoming hyperproliferative and migratory and secreting cytokines and growth factors, for which b 1 -integrin is particularly important (Goldfinger Journal of General Virology 95 et al., 1999; Grose et al., 2002; Kim et al., 1992; Larjava et al., 1993; Sivamani et al., 2007) . Synergy between keratinocyte activation during wounding and targeting of b 1 -integrin by E6 may have implications for previous observations of increased papilloma formation upon wounding of transgenic HPV8 E6 mice (Marcuzzi et al., 2009) . Therefore, targeting of b 1 -integrin by high-risk cutaneous E6 proteins with the YHDW motif might contribute to the higher propensity of malignant conversion upon infection with high-risk b-HPV.
In summary, these findings reveal b 1 -integrin as a novel target of high-risk b1-HPV E6 proteins, resulting in disruption of b 1 -integrin membrane localization through a conserved C-terminal YHDW motif in the E6 protein.
Expression of E6 proteins with the YHDW motif (HPV5 and -8) also increased keratinocyte migration in an in vitro wounding assay. Modulation of such processes may contribute to an increased risk of carcinogenesis and metastasis upon infection with certain HPVs in NMSC, providing new opportunities for therapeutic intervention.
METHODS
Cell culture. N-TERT cells (Dickson et al., 2000) were passaged in EpiLife 60 mM calcium medium (Life Technologies). Unless indicated otherwise, for experiments, N-TERT cells were cultured to~70 % confluence in Dulbecco's Modified Eagle Medium : F12 (3 : 1) RM+ medium at 37 uC, 10 % CO 2 . Retroviruses were produced in PT67 cells as described previously and used to express the pLXSN E6 constructs (Akgül et al., 2010; Tomlins & Storey, 2010) . Briefly, PT67 cells were transfected with the pLXSN E6 constructs and successful transfectants were selected by antibiotic resistance (500 mg G418 ml
21
; Sigma) and grown to confluence. A temperature shift to 32 uC for 16 h induced production of retrovirus-containing particles. The retroviral particle-containing supernatants were spun onto N-TERT cells. Twenty-four hours later, cells successfully expressing the pLXSN constructs were selected using G418.
Peptide pull-down and MS analysis. Peptides were synthesized and purified by high-performance LC by K. Di Gleria of the peptide synthesis facility, Weatherall Institute of Molecular Medicine, Oxford, UK. A lysate of N-TERT cells grown to confluence in EpiLife medium was prepared using tandem affinity purification lysis buffer [20 mM Tris/HCl (pH 8), 0.3 M KCl, 5 mM MgCl 2 , 10 % glycerol, 0.1 % Tween 20, 10 mM b-mercaptoethanol and protease inhibitors] and two freeze/thaw cycles. The lysate was pre-cleared with Sepharose beads for 1 h before dividing equally and incubating with 150 nmol control or YHDW peptide. Sixteen hours later, the peptides were precipitated using anti-HA-conjugated Sepharose beads. Interacting proteins were eluted in 26 SDS loading buffer and separated using 4-12 % gradient gel NuPAGE electrophoresis (Life Technologies). Proteins were visualized by silver staining (SilverQuest; Life Technologies). Regions of the gel identified visually as differing between the control and YHDW peptide were extracted. The proteins were subjected to trypsin digest and the peptides identified by LC-MS.
Immunofluorescence. Cells were seeded on coverslips. At~70 % confluence, the medium was removed and the cells washed in PBS and fixed in 4 % paraformaldehyde/PBS on ice for 10 min. The cells were washed and permeabilized with 0.1 % saponin/PBS or 0.5 % Triton X-100/PBS for 4 min at room temperature and blocked with 10 % BSA blocker/PBS for 30 min at room temperature. The fixed cells were incubated with the indicated primary antibody, diluted 1 : 1000, for 1 h at room temperature in 3 % BSA blocker/PBS. The cells were washed three times with PBS and incubated with Alexa Fluor 488-conjugated rabbit anti-mouse or Alexa Fluor 568-conjugated goat anti-rabbit secondary antibodies, as appropriate (Life Technologies). For saponin permeabilization, antibody incubations were performed with the addition of 0.1 % saponin.
Immunofluorescence was imaged using a Zeiss LSM 510 META confocal microscope.
Antibodies. The antibodies used were as follows: anti-paxillin (BD Bioscience), anti-vinculin (clone SPM227; Abcam), anti-b 1 -integrin (clone P5D2; Covance) and anti-FAK (Cell Signalling).
Western blotting. Cells were washed with PBS, collected by scraping and lysed on ice for at least 30 min. Lysis buffer comprised 20 mM Tris/ HCl (pH 7.5), 1 mM EDTA, 150 mM NaCl, 1 % Triton X-100, 0.5 % sodium deoxycholate, 0.1 % SDS and 16 protease inhibitors (Roche). Lysates were microfuged (15 000 r.p.m. for 15 min at 4 uC; Eppendorf centrifuge 5415R) and protein quantification was carried out using NanoDrop by measuring absorbance at 280 nm. The resulting protein extracts were separated by SDS-PAGE and electroblotted onto nitrocellulose membranes.
The secondary antibodies for Western blotting were HRP-conjugated goat anti-mouse or goat anti-rabbit (used at a dilution of 1 : 2000; Dako). Reactive proteins were visualized by chemiluminescence with ECL Plus (Amersham).
Scratch-wound assay. Cells were seeded on coverslips coated with rat tail collagen I and grown to confluence. Cell proliferation was inhibited by treatment with 10 mg mitomycin C ml 21 for 1 h. A scratch in the cell monolayer was created using 10 ml pipette tip. Cells were washed twice with PBS to remove any detached cells and new culture medium was added. At 6 h post-scratch, the cells were fixed in 4 % paraformaldehyde/PBS for 10 min at room temperature, permeabilized with 0.5 % Triton X-100/PBS for 4 min and blocked with 3 % BSA blocker/PBS. Cells were then stained with the F-actinspecific toxin phalloidin, conjugated directly to Alexa Fluor 635 (Life Technologies) and washed three times with PBS before mounting with fluoromount containing DAPI for nuclear DNA staining.
Migration assay. Cells were seeded in EssenBio ImageLock plates coated with rat tail collagen I, grown to confluence, treated with mitomycin C and scratched as above. New culture medium was added and the cells monitored for migration using an Incucyte live cell imaging system (EssenBio). Images at three distinct points of each wound were taken at 2 h intervals for a total of 10 h. The Incucyte software then calculated the mean percentage relative wound closure for each well at each time point.
Statistical methods. Statistics were calculated using one-way ANOVA to compare the mean percentage wound closure of cells expressing the different E6 constructs at the given time points. The mean percentage wound closure of cells expressing HPV5, -8 or -20 E6 was compared with that of cells expressing the empty vector or HPV5 E6, as indicated. The mean percentage wound closure of cells expressing the HPV5 E6 mutants (D156A or W157A) was compared with that of cells expressing the HPV5 E6 construct. P values were calculated using a Dunnett post-hoc test. Calculations were performed using GraphPad Prism 6 software.
